← Eichor
Study identifier: NCT07274267 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Inspiratory Muscle Training in Patients With Inflammatory Myopathy

Condition: Inflammatory Myopathies  ·  Sponsor: Józef Piłsudski University of Physical Education

PhaseNA
Planned participants33
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Inflammatory myopathies are rare autoimmune diseases leading to progressive muscle weakness, often including the respiratory muscles. This study aims to investigate whether inspiratory muscle training (IMT) using a threshold device can improve functional status in patients with inflammatory myopathy. Thirty-three patients will undergo a 3-month home-based IMT program with progressive resistance. Functional capacity, inspiratory muscle strength, lung function, diaphragmatic mobility, fatigue, and quality of life will be assessed at baseline and during follow-up. The primary hypothesis is that IMT will enhance inspiratory muscle strength and translate into better functional performance and quality of life.

This description comes directly from the study's public registry record.

Talk to the study team

Jan Sznajder, PhD  ·  +48696994812  ·  jan.sznajder@awf.edu.pl

Agnieszka Lewińska, PhD  ·  +48790013404  ·  agnieszka.lewinska@awf.edu.pl

Always discuss trial participation with your own doctor first.

Locations (1)

University Clinical Center of the Medical University of WarsawWarsaw, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07274267